End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | -2.23% | -4.37% | +12.42% |
May. 23 | Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing | MT |
May. 10 | Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.42% | 327M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- ZURA Stock
- News Zura Bio Limited
- Zura Bio Partners With Benaroya Research Institute for Research on Immune-Mediated Disorders